#Dermatology providers have a unique responsibility to select optimal treatment strategies for patients with #psoriasis while also educating them on potential complications associated with tattooing. https://t.co/mgRe6zwL7L
[NEW!] Drs. Mariwalla & Han discuss how the sophisticated formulation of sunscreen with Cloud-Tech™ exemplifies @Neutrogena's continued leadership in photoprotection innovation and its commitment to advancing #sunscreen performance and experience. https://t.co/I5lDKjwAqv
Pediatric #dermatologists are in high demand. Integrating advanced practice providers (APPs) into regular practice can expand access, but data is limited on current practice trends for APPs in the field. This study looked to evaluate the current training, setting, and practice patterns for APPs in #pediatric #dermatology. https://t.co/r3373xDdhO
The US FDA approved changes to the iPLEDGE REMS Program, designed to reduce administrative burdens while maintaining safety for acne patients taking isotretinoin-containing drugs, officially take effect on Nov. 15, 2026. Shanna M. Miranti, MPAS, PA-C, reviews what is changing and what is staying the same. https://t.co/SgrwUPYvUW
Join Leigh Ann Pansch, MSN, FNP-BC, DCNP, for a discussion on earlier intervention with #COSENTYX® (secukinumab).
🔗REGISTER HERE: https://t.co/NYrxTfdYMu
Tapinarof cream, 1% (#Vtama, @OrganonLLC), demonstrated consistent efficacy in #atopicdermatitis across diverse patient subgroups, according to a post hoc sub-analysis of pooled data from the Phase 3 ADORING 1 & 2 pivotal trials that was presented at #ACAAI2026. https://t.co/ShcgWoYtiw
November marks National #HealthySkinMonth, and @AADskin is reminding the public to appreciate and protect the skin they are in.
The group advises that people learn how to perform a skin self-exam to check their own skin for signs of skin cancer, adopt a simple and consistent skin care routine that protects and strengthens the skin barrier, and remember that skin changes can sometimes signal a health issue elsewhere in the body. Read more: https://t.co/r0BKcjQM85
Brittony Croasdell, MS, FNP-BC, APRN, CANS, the Owner & Clinical Director of Fulcrum Aesthetics & Surgery, recently sat down with JDNPPA to answer our readers’ most pressing questions about the potential role of #peptides & LED devices in #aesthetics. Here’s what she had to say! https://t.co/ThqfFLbf3J
Bimekizumab (#Bimzelx, UCB) bested risankizumab (Skyrizi, @abbvie) in achieving @ACRheum 50 responses at Week 24 in patients with active #psoriaticarthritis (PsA), according to results from the BE BOLD trial presented at ACR Convergence 2026. https://t.co/zSv8CEZ126
Patients with chronic spontaneous #urticaria (CSU) may experience relentless itch, disrupted sleep, and significant impairment in quality of life, even when there is little—or nothing—to see on physical examination. https://t.co/BEmRjQkP30
National #NursePractitioner Week is held annually to celebrate these exceptional health care providers & to remind lawmakers of the importance of removing outdated barriers to practice so NPs can practice to the full extent of their experience & education.
#NPWeek
A 12-year-old boy presented to the dermatology clinic with a history of a persistent rash on one foot that had been present for more than one year. Prior to the #dermatology referral, the patient had been treated with oral griseofulvin, topical antifungal agents, and at least one additional unspecified antifungal medication for longer than a month. The patient’s mother reported that these treatments had provided some improvement but had not resolved the condition. No one else in the family had any similar rash or skin eruption, and the patient reported no other area of rash, itch, or concern on his body. https://t.co/6v78B8fCrm
Current barriers to early PsA detection are multifactorial and systemic. Many patients with psoriasis remain unaware of their risk for developing arthritis, leading to delays in reporting musculoskeletal symptoms. https://t.co/IMuKeXSibo
The management of severe #atopicdermatitis (AD) in children under age 12 remains a significant clinical challenge. https://t.co/nCoyg9XvUH
#EczemaAwarenessMonth
The vast majority of patients with #atopicdermatitis (AD) have mild-or-moderate disease, and topical therapies are a mainstay of treatment. Corticosteroids are commonly used as a first-line topical treatment, but their safety profile leads to restrictions on sites and duration of use and can create “steroid phobia” among patients & caregivers, resulting in refusal of these agents or adherence issues. https://t.co/ogcvc8fkXX
#Dermatology providers have a unique responsibility to select optimal treatment strategies for patients with #psoriasis while also educating them on potential complications associated with tattooing. https://t.co/mgRe6zwL7L
Join Leigh Ann Pansch, MSN, FNP-BC, DCNP, for a discussion on earlier intervention with #COSENTYX® (secukinumab).
🔗REGISTER HERE: https://t.co/NYrxTfdYMu
November marks National #HealthySkinMonth, and @AADskin is reminding the public to appreciate and protect the skin they are in.
The group advises that people learn how to perform a skin self-exam to check their own skin for signs of skin cancer, adopt a simple and consistent skin care routine that protects and strengthens the skin barrier, and remember that skin changes can sometimes signal a health issue elsewhere in the body. Read more: https://t.co/r0BKcjQM85